Sandip Basu1, Thomas C Kwee, Babak Saboury, Jonathan P Garino, Charles L Nelson, Hongming Zhuang, Molly Parsons, Wengen Chen, Rakesh Kumar, Ali Salavati, Thomas J Werner, Abass Alavi. 1. From the *Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, PA; †Radiation Medicine Centre (BARC), Tata Memorial Centre Annexe, Parel, Bombay, Maharashtra, India; ‡Department of Radiology, University Medical Center Utrecht, Utrecht, Utrecht, the Netherlands; §Department of Orthopedic Surgery, Penn Presbyterian Medical Center, Philadelphia, PA; ¶Department of Radiology, Children's Hospital of Philadelphia, Philadelphia, PA; and ∥Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, Delhi, India.
Abstract
PURPOSE: This study aims to assess and compare the value of FDG PET with combined In-labeled leukocyte/Tc-sulfur colloid bone marrow (WBC/BM) imaging for diagnosing infection in hip and knee prostheses. METHODS: In this prospective study, patients with painful hip or knee arthroplasty, who were scheduled to undergo clinical and diagnostic evaluation for prosthesis revision, were included. They have been studied by using FDG PET and WBC/BM scan. This study was institutional review board approved and Health Insurance Portability and Accountability Act compliant. All patients provided written informed consent. RESULTS: A total of 134 hip and 87 knee prostheses, suspected of being either infected or noninfectious loosening, were evaluated. All 221 prostheses underwent FDG PET, whereas both WBC/BM imaging and FDG PET were performed in 88 prostheses. The initial analysis of data from the WBC/BM images demonstrated somewhat suboptimal results compared with those of FDG PET scans on 88 patients. In addition, some patients were not willing to undergo both procedures and therefore participate in this study. Therefore, a decision was made to eliminate WBC/BM imaging from the procedures for the remainder of this research study. This decision was reached partly because of the significant radiation dose delivered from labeled WBC and safety issues related to preparing these labeled cells. Final diagnosis was based on microbiological examinations of the surgical specimens in 125 prostheses and joint aspirations combined with the clinical follow-up of 6 months or more in 86 prostheses. The sensitivity, specificity, positive predictive value, and negative predictive value of FDG PET in hip prostheses were 81.8%, 93.1%, 79.4%, and 94.0%, respectively, and in knee prostheses were 94.7%, 88.2%, 69.2%, and 98.4%, respectively. The sensitivity, specificity, positive predictive value, and negative predictive value of WBC/BM imaging in hip prostheses were 38.5%, 95.7%, 71.4%, and 84.6%, respectively, and in knee prostheses were 33.3%, 88.5%, 25.0%, and 92.0%, respectively. In those cases that underwent both FDG PET and WBC/BM imaging, there was a trend (P = 0.0625) toward a higher sensitivity for FDG PET in hip prostheses, whereas other comparisons did not show any significant differences between the 2 imaging modalities. CONCLUSIONS: Based on this study, the diagnostic performance of FDG PET scan in detecting infection in painful hip and knee prostheses is optimal for routine clinical application. Considering the complexity and costs of WBC/BM imaging and related safety issues associated with this preparation, FDG PET seems to be an appropriate alternative for assessing these patients.
PURPOSE: This study aims to assess and compare the value of FDG PET with combined In-labeled leukocyte/Tc-sulfur colloid bone marrow (WBC/BM) imaging for diagnosing infection in hip and knee prostheses. METHODS: In this prospective study, patients with painful hip or knee arthroplasty, who were scheduled to undergo clinical and diagnostic evaluation for prosthesis revision, were included. They have been studied by using FDG PET and WBC/BM scan. This study was institutional review board approved and Health Insurance Portability and Accountability Act compliant. All patients provided written informed consent. RESULTS: A total of 134 hip and 87 knee prostheses, suspected of being either infected or noninfectious loosening, were evaluated. All 221 prostheses underwent FDG PET, whereas both WBC/BM imaging and FDG PET were performed in 88 prostheses. The initial analysis of data from the WBC/BM images demonstrated somewhat suboptimal results compared with those of FDG PET scans on 88 patients. In addition, some patients were not willing to undergo both procedures and therefore participate in this study. Therefore, a decision was made to eliminate WBC/BM imaging from the procedures for the remainder of this research study. This decision was reached partly because of the significant radiation dose delivered from labeled WBC and safety issues related to preparing these labeled cells. Final diagnosis was based on microbiological examinations of the surgical specimens in 125 prostheses and joint aspirations combined with the clinical follow-up of 6 months or more in 86 prostheses. The sensitivity, specificity, positive predictive value, and negative predictive value of FDG PET in hip prostheses were 81.8%, 93.1%, 79.4%, and 94.0%, respectively, and in knee prostheses were 94.7%, 88.2%, 69.2%, and 98.4%, respectively. The sensitivity, specificity, positive predictive value, and negative predictive value of WBC/BM imaging in hip prostheses were 38.5%, 95.7%, 71.4%, and 84.6%, respectively, and in knee prostheses were 33.3%, 88.5%, 25.0%, and 92.0%, respectively. In those cases that underwent both FDG PET and WBC/BM imaging, there was a trend (P = 0.0625) toward a higher sensitivity for FDG PET in hip prostheses, whereas other comparisons did not show any significant differences between the 2 imaging modalities. CONCLUSIONS: Based on this study, the diagnostic performance of FDG PET scan in detecting infection in painful hip and knee prostheses is optimal for routine clinical application. Considering the complexity and costs of WBC/BM imaging and related safety issues associated with this preparation, FDG PET seems to be an appropriate alternative for assessing these patients.
Authors: H Zhuang; P S Duarte; M Pourdehnad; A Maes; F Van Acker; D Shnier; J P Garino; R H Fitzgerald; A Alavi Journal: J Nucl Med Date: 2001-01 Impact factor: 10.057
Authors: Benedicte Vanquickenborne; Alex Maes; Johan Nuyts; Frank Van Acker; Jos Stuyck; Michiel Mulier; Alfons Verbruggen; Luc Mortelmans Journal: Eur J Nucl Med Mol Imaging Date: 2003-03-04 Impact factor: 9.236
Authors: Benjamin Zmistowski; Craig Della Valle; Thomas W Bauer; Konstantinos N Malizos; Abbas Alavi; Hani Bedair; Robert E Booth; Peter Choong; Carl Deirmengian; Garth D Ehrlich; Anil Gambir; Ronald Huang; Yair Kissin; Hideo Kobayashi; Naomi Kobayashi; Veit Krenn; Lorenzo Drago; Drago Lorenzo; S B Marston; Geert Meermans; Javier Perez; J J Ploegmakers; Aaron Rosenberg; C Simpendorfer; Peter Thomas; Stephan Tohtz; Jorge A Villafuerte; Peter Wahl; Frank-Christiaan Wagenaar; Eivind Witzo Journal: J Arthroplasty Date: 2013-12-15 Impact factor: 4.757
Authors: Mehrsima Abdoli; Johan R de Jong; Jan Pruim; Rudi A J O Dierckx; Habib Zaidi Journal: Eur J Nucl Med Mol Imaging Date: 2011-08-18 Impact factor: 9.236
Authors: R L Roerdink; C M Douw; A C A P Leenders; R S Dekker; M Dietvorst; C J M Oosterbos; H T J Roerdink; R W T M Kempen; L P A Bom Journal: Infection Date: 2016-05-28 Impact factor: 3.553
Authors: Yu Wang; John M Thompson; Alyssa G Ashbaugh; Pavlo Khodakivskyi; Ghyslain Budin; Riccardo Sinisi; Andrew Heinmiller; Marleen van Oosten; Jan Maarten van Dijl; Gooitzen M van Dam; Kevin P Francis; Nicholas M Bernthal; Elena A Dubikovskaya; Lloyd S Miller Journal: J Am Acad Orthop Surg Date: 2017-02 Impact factor: 3.020
Authors: Steven J Verberne; Remko J A Sonnega; Olivier P P Temmerman; Pieter G Raijmakers Journal: Clin Orthop Relat Res Date: 2017-01-03 Impact factor: 4.176